Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Laboratory Corporation Of America Holdings | 165,123 | 225,902 | +60,779 | $37.53M | $49.35M | 17.19% | +$11.82M |
| The Cigna Group(CI) | 116,553 | 76,086 | -40,467 | $34.90M | $27.63M | 9.62% | -$7.27M |
| Globus Medical, Inc.CL A(GMED) | 532,089 | 393,420 | -138,669 | $28.36M | $21.10M | 7.35% | -$7.25M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 0 | 51,000 | +51,000 | $0 | $13.62M | 4.74% | +$13.62M |
| GSK plcADR(GSK) | 571,391 | 263,445 | -307,946 | $21.18M | $11.29M | 3.93% | -$9.88M |
| Zimmer Biomet Holdings, Inc.(ZBH) | 72,300 | 74,179 | +1,879 | $8.80M | $9.79M | 3.41% | +$991.2K |
| Medtronic plcSHS(MDT) | 0 | 105,000 | +105,000 | $0 | $9.15M | 3.19% | +$9.15M |
| Organon & Co.(OGN) | 0 | 479,023 | +479,023 | $0 | $9.01M | 3.14% | +$9.01M |
| Tyra Biosciences, Inc.(TYRA) | 0 | 535,741 | +535,741 | $0 | $8.79M | 3.06% | +$8.79M |
| Embecta Corp.(EMBC) | 736,008 | 585,418 | -150,590 | $13.93M | $7.77M | 2.71% | -$6.16M |
| Teleflex Incorporated(TFX) | 36,527 | 33,878 | -2,649 | $9.11M | $7.66M | 2.67% | -$1.45M |
| Arcutis Biotherapeutics, Inc.(ARQT) | 635,969 | 635,969 | 0 | $2.05M | $6.30M | 2.19% | +$4.25M |
| BridgeBio Pharma, Inc.(BBIO) | 131,753 | 203,174 | +71,421 | $5.32M | $6.28M | 2.19% | +$963.3K |
| Humacyte, Inc.(HUMA) | 0 | 2,000,000 | +2,000,000 | $0 | $6.22M | 2.17% | +$6.22M |
| ANI Pharmaceuticals, Inc.(ANIP) | 0 | 87,354 | +87,354 | $0 | $6.04M | 2.10% | +$6.04M |
| Astria Therapeutics Inc | 0 | 410,267 | +410,267 | $0 | $5.77M | 2.01% | +$5.77M |
| ARS Pharmaceuticals, Inc.(SPRY) | 1,105,911 | 536,163 | -569,748 | $6.06M | $5.48M | 1.91% | -$580.8K |
| Healthcare Services Group, Inc.(HCSG) | 810,307 | 421,317 | -388,990 | $8.40M | $5.26M | 1.83% | -$3.14M |
| Apogee Therapeutics Inc | 0 | 78,000 | +78,000 | $0 | $5.18M | 1.81% | +$5.18M |
| Fusion Pharmaceuticals Inc | 246,036 | 243,035 | -3,001 | $2.36M | $5.18M | 1.80% | +$2.82M |
| Erasca, Inc.(ERAS) | 0 | 2,427,184 | +2,427,184 | $0 | $5.00M | 1.74% | +$5.00M |
| X4 Pharmaceuticals, Inc.(XFOR) | 3,588,427 | 3,588,427 | 0 | $3.01M | $4.99M | 1.74% | +$1.98M |
| Nuvation Bio Inc.CL A(NUVB) | 0 | 1,336,231 | +1,336,231 | $0 | $4.86M | 1.69% | +$4.86M |
| Scholar Rock Holding Corporation(SRRK) | 0 | 273,720 | +273,720 | $0 | $4.86M | 1.69% | +$4.86M |
| Integra LifeSciences Holdings Corporation(IART) | 0 | 137,000 | +137,000 | $0 | $4.86M | 1.69% | +$4.86M |
| Ocular Therapeutix, Inc.(OCUL) | 971,446 | 383,026 | -588,420 | $4.33M | $3.49M | 1.21% | -$847.1K |
| CytomX Therapeutics, Inc.(CTMX) | 0 | 1,598,590 | +1,598,590 | $0 | $3.48M | 1.21% | +$3.48M |
| Enanta Pharmaceuticals, Inc.(ENTA) | 0 | 177,004 | +177,004 | $0 | $3.09M | 1.08% | +$3.09M |
| Stoke Therapeutics, Inc.(STOK) | 0 | 225,496 | +225,496 | $0 | $3.04M | 1.06% | +$3.04M |
| Modular Medical Inc | 689,352 | 1,539,352 | +850,000 | $1.25M | $2.85M | 0.99% | +$1.59M |
| Rapt Therapeutics Inc | 0 | 315,000 | +315,000 | $0 | $2.83M | 0.99% | +$2.83M |
| Revance Therapeutics Inc | 0 | 468,871 | +468,871 | $0 | $2.31M | 0.80% | +$2.31M |
| Ventyx Biosciences Inc | 0 | 378,000 | +378,000 | $0 | $2.08M | 0.72% | +$2.08M |
| Boundless Bio, Inc.(BOLD) | 0 | 143,000 | +143,000 | $0 | $2.04M | 0.71% | +$2.04M |
| Aprea Therapeutics, Inc.(APRE) | 280,000 | 276,603 | -3,397 | $1.32M | $1.85M | 0.64% | +$534.5K |
| Third Harmonic Bio Inc | 163,363 | 163,363 | 0 | $1.79M | $1.54M | 0.54% | -$249.9K |
| Prelude Therapeutics Incorporated(PRLD) | 320,394 | 320,394 | 0 | $1.37M | $1.52M | 0.53% | +$150.6K |
| IDEAYA Biosciences, Inc.(IDYA) | 33,007 | 33,007 | 0 | $1.17M | $1.45M | 0.50% | +$274.0K |
| Ironwood Pharmaceuticals, Inc.CL A(IRWD) | 0 | 149,400 | +149,400 | $0 | $1.30M | 0.45% | +$1.30M |
| Foghorn Therapeutics Inc.(FHTX) | 121,672 | 121,672 | 0 | $784.8K | $816.4K | 0.28% | +$31.6K |
| Nyxoah SaSHS SHS | 200,076 | 50,839 | -149,237 | $928.4K | $685.8K | 0.24% | -$242.5K |
| Vincerx Pharma Inc | 102,049 | 102,049 | 0 | $120.4K | $516.4K | 0.18% | +$395.9K |
| Nextcure Inc | 130,000 | 130,000 | 0 | $148.2K | $289.9K | 0.10% | +$141.7K |
| Avalo Therapeutics, Inc.(AVTX) | 0 | 10,151 | +10,151 | $0 | $220.8K | 0.08% | +$220.8K |
| Aslan Pharmaceuticals LtdADS | 254,150 | 254,150 | 0 | $132.7K | $156.4K | 0.05% | +$23.7K |
| Rocket Pharmaceuticals, Inc.W EXP 09 02 202(RCKT) | 400,000 | 400,000 | 0 | $172.0K | $109.9K | 0.04% | -$62.1K |
| Humacyte, Inc.W EXP 08 27 202(HUMA) | 49,998 | 49,998 | 0 | $21.6K | $31.0K | 0.01% | +$9.4K |
| Caremax IncW EXP 06 08 202 | 12,808 | 12,808 | 0 | $175 | $302 | 0.00% | +$127 |
| Caremax IncCL A | 30,741 | 0 | -30,741 | $15.3K | $0 | — | -$15.3K |
| COMPASS Pathways plcADS(CMPS) | 251,532 | 0 | -251,532 | $2.20M | $0 | — | -$2.20M |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 150,000 | 0 | -150,000 | $906.0K | $0 | — | -$906.0K |
| Gracell Biotechnologies IncADS | 5,001,580 | 0 | -5,001,580 | $50.22M | $0 | — | -$50.22M |
| Harpoon Therapeutics Inc | 297,936 | 0 | -297,936 | $3.39M | $0 | — | -$3.39M |
| Immunogen Inc | 644,366 | 0 | -644,366 | $19.11M | $0 | — | -$19.11M |
| Inogen, Inc.(INGN) | 52,794 | 0 | -52,794 | $289.8K | $0 | — | -$289.8K |
| Merrimack Pharmaceuticals In | 288,466 | 0 | -288,466 | $3.87M | $0 | — | -$3.87M |
| Mirati Therapeutics Inc | 1,451,925 | 0 | -1,451,925 | $85.30M | $0 | — | -$85.30M |
| Protagonist Therapeutics Inc | 460,044 | 0 | -460,044 | $10.55M | $0 | — | -$10.55M |
| United Therapeutics Corporation(UTHR) | 80,050 | 0 | -80,050 | $17.60M | $0 | — | -$17.60M |
| Vanda Pharmaceuticals Inc.(VNDA) | 97,616 | 0 | -97,616 | $411.9K | $0 | — | -$411.9K |